Michael Markert

819 total citations
39 papers, 578 citations indexed

About

Michael Markert is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, Michael Markert has authored 39 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 7 papers in Animal Science and Zoology. Recurrent topics in Michael Markert's work include Cardiac electrophysiology and arrhythmias (10 papers), Pharmacological Effects and Assays (7 papers) and Heart Rate Variability and Autonomic Control (7 papers). Michael Markert is often cited by papers focused on Cardiac electrophysiology and arrhythmias (10 papers), Pharmacological Effects and Assays (7 papers) and Heart Rate Variability and Autonomic Control (7 papers). Michael Markert collaborates with scholars based in Germany, Belgium and United Kingdom. Michael Markert's co-authors include Brian D. Guth, Thomas Trautmann, Julia Henke, Sabine Tacke, Karin Mayer, H. Bresch, Simon Chivers, Peter K. S. Siegl, M. Pairet and Richard J. Briscoe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and International Journal of Pharmaceutics.

In The Last Decade

Michael Markert

35 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Markert Germany 14 279 157 115 47 42 39 578
Rob Wallis United Kingdom 12 142 0.5× 163 1.0× 59 0.5× 54 1.1× 8 0.2× 23 445
Annie Delaunois Belgium 14 97 0.3× 254 1.6× 41 0.4× 102 2.2× 13 0.3× 69 721
John H. Weikel United States 13 120 0.4× 147 0.9× 39 0.3× 51 1.1× 23 0.5× 30 684
Günter Scholtysik Switzerland 10 228 0.8× 301 1.9× 20 0.2× 102 2.2× 13 0.3× 21 580
Elisha J. Hamilton Australia 19 332 1.2× 570 3.6× 14 0.1× 45 1.0× 44 1.0× 34 994
M. Schöneshöfer Germany 20 65 0.2× 211 1.3× 14 0.1× 24 0.5× 57 1.4× 67 1.0k
K Becker Germany 14 158 0.6× 159 1.0× 8 0.1× 44 0.9× 51 1.2× 44 533
Stephen Krop United States 13 149 0.5× 112 0.7× 17 0.1× 66 1.4× 11 0.3× 36 578
Elżbieta Kompanowska‐Jezierska Poland 19 470 1.7× 171 1.1× 22 0.2× 18 0.4× 24 0.6× 85 999
P Duchêne-Marullaz France 15 407 1.5× 285 1.8× 22 0.2× 112 2.4× 25 0.6× 109 676

Countries citing papers authored by Michael Markert

Since Specialization
Citations

This map shows the geographic impact of Michael Markert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Markert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Markert more than expected).

Fields of papers citing papers by Michael Markert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Markert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Markert. The network helps show where Michael Markert may publish in the future.

Co-authorship network of co-authors of Michael Markert

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Markert. A scholar is included among the top collaborators of Michael Markert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Markert. Michael Markert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rast, Georg, Thomas Trautmann, Guido R.Y. De Meyer, et al.. (2025). Implementation of automated blood sampling in a canine cardiovascular safety pharmacology study to support PK/PD assessment. Journal of Pharmacological and Toxicological Methods. 135. 107764–107764.
2.
Liu, Haibo, et al.. (2023). Comparison of statistical, machine learning, and mathematical modelling methods to investigate the effect of ageing on dog’s cardiovascular system. SHILAP Revista de lepidopterología. 73. 2–27. 1 indexed citations
3.
Rast, Georg, Florian Krause, Guido R.Y. De Meyer, et al.. (2023). Optimization of bioanalysis of dried blood samples. Journal of Pharmacological and Toxicological Methods. 123. 107296–107296. 3 indexed citations
4.
Trautmann, Thomas, et al.. (2023). Thirty years of telemetry-based data acquisition for cardiovascular drug safety evaluation: Applications and optimization. Journal of Pharmacological and Toxicological Methods. 122. 107279–107279. 2 indexed citations
5.
Markert, Michael. (2022). „Es besteht hier immer Bedarf an frischen Embryonen.“. 106(1). 86–122.
6.
7.
Markert, Michael. (2020). Modellierte Individualentwicklung. Humanembryologische Praktiken an der Universität Göttingen in der zweiten Hälfte des 20. Jahrhunderts. NTM Zeitschrift für Geschichte der Wissenschaften Technik und Medizin. 28(4). 481–517. 1 indexed citations
8.
Markert, Michael, et al.. (2018). Annals of the History and Philosophy of Biology 21/2016. GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen). 1 indexed citations
9.
Tseng, Yin‐Chao, et al.. (2016). Cardiovascular safety pharmacology studies in dogs enabled for a poorly soluble molecule using spray-dried dispersion: Impact on lead selection. International Journal of Pharmaceutics. 512(1). 137–146. 1 indexed citations
10.
Oost, Thorsten, Armin Heckel, Thorsten Lehmann, et al.. (2015). Design, synthesis and evaluation of MCH receptor 1 antagonists—Part III: Discovery of pre-clinical development candidate BI 186908. Bioorganic & Medicinal Chemistry Letters. 25(16). 3275–3280. 6 indexed citations
11.
Müller, Stephan, Armin Heckel, Thorsten Lehmann, et al.. (2015). Design, synthesis and evaluation of MCH receptor 1 antagonists—Part I: Optimization of HTS hits towards an in vivo efficacious tool compound BI 414. Bioorganic & Medicinal Chemistry Letters. 25(16). 3264–3269. 2 indexed citations
12.
Markert, Michael, et al.. (2012). Evaluation of a method to correct the contractility index LVdP/dtmax for changes in heart rate. Journal of Pharmacological and Toxicological Methods. 66(2). 98–105. 17 indexed citations
13.
Markert, Michael, Ruijun Shen, Thomas Trautmann, & Brian D. Guth. (2011). Heart rate correction models to detect QT interval prolongation in novel pharmaceutical development. Journal of Pharmacological and Toxicological Methods. 64(1). 25–41. 10 indexed citations
14.
Markert, Michael, et al.. (2009). Validation of the normal, freely moving Göttingen minipig for pharmacological safety testing. Journal of Pharmacological and Toxicological Methods. 60(1). 79–87. 28 indexed citations
15.
Guth, Brian D., Richard J. Briscoe, Simon Chivers, et al.. (2009). Comparison of electrocardiographic analysis for risk of QT interval prolongation using safety pharmacology and toxicological studies. Journal of Pharmacological and Toxicological Methods. 60(2). 107–116. 41 indexed citations
16.
Trautmann, Thomas, et al.. (2006). Optimizing the experimental environment for dog telemetry studies. Journal of Pharmacological and Toxicological Methods. 54(2). 141–149. 39 indexed citations
17.
Guth, Brian D., et al.. (2004). Developing a strategy for the nonclinical assessment of proarrhythmic risk of pharmaceuticals due to prolonged ventricular repolarization. Journal of Pharmacological and Toxicological Methods. 49(3). 159–169. 61 indexed citations
18.
Markert, Michael, et al.. (2004). A novel propellant-free inhalation drug delivery system for cardiovascular drug safety evaluation in conscious dogs. Journal of Pharmacological and Toxicological Methods. 50(2). 109–119. 15 indexed citations
19.
Markert, Michael, et al.. (2000). Continuous assessment of multiple vital physiological functions in conscious freely moving rats using telemetry and a plethysmography system. Journal of Pharmacological and Toxicological Methods. 43(3). 211–217. 25 indexed citations
20.
Nagel, Roland, H. Bresch, Norbert Caspers, et al.. (1991). Effect of 3,4-dichloroaniline on the early life stages of the zebrafish (Brachydanio retio): Results of a comparative laboratory study. Ecotoxicology and Environmental Safety. 21(2). 157–164. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rob Wallis Breakdown of academic impact, for papers by Annie Delaunois Breakdown of academic impact, for papers by John H. Weikel Breakdown of academic impact, for papers by Günter Scholtysik Breakdown of academic impact, for papers by Elisha J. Hamilton Breakdown of academic impact, for papers by M. Schöneshöfer Breakdown of academic impact, for papers by K Becker Breakdown of academic impact, for papers by Stephen Krop Breakdown of academic impact, for papers by Elżbieta Kompanowska‐Jezierska Breakdown of academic impact, for papers by P Duchêne-Marullaz
Rankless by CCL
2026